NETEC Resource Library

COVID-19: combining antiviral and anti-inflammatory treatments


Click for External Resource*

Click to read full article*

*The link above may share a zip file (.zip) hosted on Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Item Type


Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Share this page:

Was this resource helpful?


COVID-19: combining antiviral and anti-inflammatory treatments


Both coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) are characterised by an overexuberant inflammatory response and, for SARS, viral load is not correlated with the worsening of symptoms.

The article received comments and an author's reply:
  1. Favalli, Ennio G., Martina Biggioggero, Gabriella Maioli, and Roberto Caporali. 2020. "Baricitinib for COVID-19: a suitable treatment?" The Lancet Infectious Diseases.
  2. Richardson, Peter J., Mario Corbellino, and Justin Stebbing. 2020. "Baricitinib for COVID-19: a suitable treatment? - Authors' reply." The Lancet Infectious Diseases.




Stebbing, Justin, Anne Phelan, Ivan Griffin, Catherine Tucker, Olly Oechsle, Dan Smith, and Peter Richardson. 2020. "COVID-19: combining antiviral and anti-inflammatory treatments." The Lancet Infectious Diseases.


Free online on Lancet site.


Related Resource Topic Exhibits